We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.9B
AUM Growth
-$1.94B
Cap. Flow
-$1.04B
Cap. Flow %
-4.99%
Top 10 Hldgs %
40.27%
Holding
168
New
18
Increased
43
Reduced
28
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 37.95%
2 Technology 14.96%
3 Financials 12.32%
4 Communication Services 7.9%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBRE icon
26
CBRE Group
CBRE
$42.9B
$326M 1.57%
2,495,700
+315,900
+14% +$42.9M
ANSS
27
DELISTED
Ansys
ANSS
$300M 1.44%
948,000
SCHW
28
Charles Schwab
SCHW
$187B
$300M 1.44%
3,832,857
+663,857
+21% +$52.1M
PTGX icon
29
Protagonist Therapeutics
PTGX
$9.44B
$295M 1.42%
6,107,006
+177,000
+3% +$7.42M
WAB icon
30
Wabtec
WAB
$49.3B
$292M 1.4%
1,608,098
+177,900
+12% +$34.1M
K
31
DELISTED
Kellanova
K
$274M 1.31%
3,320,000
+2,271,182
+217% +$186M
IBIT icon
32
iShares Bitcoin Trust
IBIT
$47.8B
$271M 1.3%
5,793,800
-1,465,300
-20% -$77.6M
ADI icon
33
Analog Devices
ADI
$190B
$268M 1.28%
1,327,000
+169,800
+15% +$36.7M
GOOG icon
34
Alphabet (Google) Class C
GOOG
$4.32T
$260M 1.25%
1,666,040
-414,500
-20% -$75.9M
WWD icon
35
Woodward
WWD
$21.4B
$259M 1.24%
1,419,700
-101,600
-7% -$18.8M
HIMS icon
36
Hims & Hers Health
HIMS
$7.31B
$235M 1.13%
7,953,705
-423,295
-5% -$15.7M
BBIO icon
37
BridgeBio Pharma
BBIO
$16.5B
$198M 0.95%
5,731,000
+1,536,000
+37% +$51.8M
BEAM icon
38
Beam Therapeutics
BEAM
$2.84B
$194M 0.93%
9,928,111
+1,688,988
+20% +$44.2M
AGIO icon
39
Agios Pharmaceuticals
AGIO
$1.93B
$167M 0.8%
5,700,466
+26,000
+0.5% +$862K
V icon
40
Visa
V
$677B
$166M 0.8%
474,210
-75,300
-14% -$25.5M
CRNX icon
41
Crinetics Pharmaceuticals
CRNX
$8.92B
$154M 0.74%
4,605,098
+530,000
+13% +$19.8M
SRPT icon
42
Sarepta Therapeutics
SRPT
$1.77B
$149M 0.72%
2,341,424
-523,676
-18% -$55.1M
BHVN icon
43
Biohaven
BHVN
$2.21B
$116M 0.55%
4,813,167
+385,000
+9% +$13.6M
MA icon
44
Mastercard
MA
$493B
$110M 0.53%
201,371
-94,300
-32% -$51.3M
YMM icon
45
Full Truck Alliance
YMM
$9.99B
$94M 0.45%
7,357,207
-9,227,888
-56% -$111M
X
46
DELISTED
US Steel
X
$90.2M 0.43%
2,135,000
-1,641,000
-43% -$62.1M
CHX
47
DELISTED
ChampionX
CHX
$86.6M 0.42%
2,905,000
-930,000
-24% -$27.2M
SGI
48
Somnigroup International
SGI
$13.7B
$79.4M 0.38%
+1,326,242
New +$80.3M
WAY
49
Waystar Holding Corp
WAY
$4.65B
$75.5M 0.36%
2,020,000
+678,000
+51% +$26.8M
VRNA
50
DELISTED
Verona Pharma
VRNA
$68.9M 0.33%
+1,084,989
New +$64.9M

Similar funds

Farallon Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Farallon Capital Management held 168 positions worth $20.9B, down 8.5% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $1.04B in Q1 2025, closing 22 positions and reducing 28 holdings. Its most notable exit was Airbnb, an estimated $319M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $403M.

  • Farallon Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 3,055,000 shares worth $403M.
  • Farallon Capital Management added most to Microsoft in Q1 2025, an estimated $266M increase.
  • Farallon Capital Management's biggest Q1 2025 reduction was Aon, cutting an estimated $181M.
  • Farallon Capital Management fully exited Airbnb in Q1 2025, selling an estimated $319M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $20.9B portfolio in Q1 2025.
  • Farallon Capital Management opened 18 new positions and closed 22 in Q1 2025.
  • Farallon Capital Management's portfolio value fell 8.5% quarter-over-quarter to $20.9B.

Based on Farallon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.